Scientific Index

Overview:This 12-month, multicenter, open-label study evaluated the long-term safety and efficacy of triamcinolone acetonide (TAA) aqueous nasal spray for treating perennial allergic rhinitis (PAR). The study followed patients who had...

Overview:This multicenter, prospective, randomized, open-label study assessed the long-term safety of intranasal triamcinolone acetonide (TAA) aqueous spray in patients with perennial allergic rhinitis (PAR). The primary focus was on nasal...

Overview:This one-year, open-label extension of a prior 12-week, double-blind clinical trial assessed the long-term safety and efficacy of once-daily triamcinolone acetonide nasal aerosol in 93 patients with perennial allergic rhinitis...

Overview:This comprehensive review explores the mechanisms, pharmacokinetics, and safety profiles of intranasal corticosteroids (INSs), which are widely used to treat allergic rhinitis, rhinosinusitis, and nasal polyposis. The paper highlights the...

Overview:This multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of triamcinolone acetonide (TAA) aqueous nasal spray in 178 patients with perennial allergic rhinitis (PAR). Participants were treated once...